Clinical Trial Update: HRZE Fasted/Fed in Newly Diagnosed TB [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the HRZE regimen under fasted vs fed conditions in newly diagnosed tuberculosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Ethambutol (ethambutol)
• ISONIAZID (ISONIAZID)
• Pyrazinamide (pyrazinamide)
• Rifampicin

Snippet

Sponsor: University Medical Center Groningen | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED